Colgate-Palmolive (NYSE:CL) Shares Acquired by Integrated Investment Consultants LLC

Integrated Investment Consultants LLC increased its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 88.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,566 shares of the company's stock after acquiring an additional 12,000 shares during the period. Integrated Investment Consultants LLC's holdings in Colgate-Palmolive were worth $2,324,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive during the third quarter worth $53,000. Prospera Private Wealth LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $64,000. True Wealth Design LLC increased its holdings in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after acquiring an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC increased its stake in Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company's stock valued at $79,000 after purchasing an additional 368 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.34% of the company's stock.

Colgate-Palmolive Trading Up 0.3 %

Shares of CL traded up $0.23 on Friday, hitting $88.79. 5,149,874 shares of the stock traded hands, compared to its average volume of 3,679,883. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The stock's 50 day moving average is $92.20 and its two-hundred day moving average is $97.75. The firm has a market capitalization of $72.55 billion, a P/E ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. Colgate-Palmolive's payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CL shares. UBS Group cut their target price on Colgate-Palmolive from $112.00 to $104.00 and set a "buy" rating on the stock in a research report on Thursday. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research report on Friday. Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a "hold" rating for the company in a research report on Friday. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating on the stock in a research report on Thursday. Finally, StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.